Keywords: Puncture needle (microneedle), manufacturer, material science, degradable polymer, biocompatibility

As precision devices at the millimeter scale, microneedles are reshaping the landscape of drug delivery, medical aesthetics and diagnostic sampling with their painless and minimally invasive features. Material innovation stands as one of the core driving forces behind their technological advancement. From the first-generation metallic microneedles to the third-generation degradable polymer microneedles, each material upgrade represents more than a change in physical properties. It delivers in-depth responses to clinical demands and profoundly shapes manufacturers' R&D roadmaps and market strategies.

I. Generational Evolution of Materials: From Rigid Penetration to Intelligent Dissolution

The development of microneedle materials can be clearly divided into three generations. Each generation addresses the drawbacks of its predecessor and expands application boundaries.

1. First Generation: Metallic and Silicon-based Microneedles - Foundational Technology and Limitations

• Representative materials: Stainless steel, titanium alloy, monocrystalline silicon.
• Manufacturer considerations: Thanks to exceptional mechanical strength, corrosion resistance and mature processing techniques such as precision grinding and laser cutting, stainless steel and titanium alloy were mainstream choices for early solid microneedles. They reliably penetrate the stratum corneum to create microchannels. Leveraging sophisticated Micro-Electro-Mechanical Systems (MEMS) technology, monocrystalline silicon enables ultra-high machining accuracy and complex array structures.

Nevertheless, metallic microneedles may cause mild pain and psychological discomfort during use, with a low risk of needle breakage and residual fragments. Silicon is brittle and prone to fracture, while its long-term biocompatibility remains questionable. For manufacturers, materials of this generation feature mature technology and stable supply chains, yet they result in severe product homogeneity and low added value.

2. Second Generation: Non-soluble Polymer Microneedles - Exploration of Flexibility

• Representative materials: Engineering plastics including Polycarbonate (PC), Polyether Ether Ketone (PEEK) and Polymethyl Methacrylate (PMMA).
• Manufacturer considerations: Polymer materials offer superior flexibility and biocompatibility, enabling the fabrication of flexible patches that fit the contours of human skin. Mass production at low cost can be realized via injection molding.

However, the core limitation lies in the fact that the needle bodies remain as foreign substances on the skin surface or require removal after use, failing to deliver a completely imperceptible experience. They also lack flexibility in drug loading and release control.

3. Third Generation: Dissolvable/Degradable Polymer Microneedles - Current Focus and Future Direction

This category has become an absolute hotspot for R&D and industrialization.

• Natural polymers: Hyaluronic acid, silk fibroin and chitosan. They possess favorable biocompatibility and bioactivity, yet challenges exist in controlling mechanical strength and batch consistency.
• Synthetic polymers: Polylactic Acid (PLA), Poly(lactic-co-glycolic acid) (PLGA), Polyvinylpyrrolidone (PVP) and Polyvinyl Alcohol (PVA). These materials have obtained certifications such as FDA approval with guaranteed safety. They dissolve or degrade in skin interstitial fluid, fully release encapsulated drugs and disappear afterwards, achieving genuine non-invasive application.
• Core breakthroughs by manufacturers: Third-generation materials endow microneedles with unprecedented intelligence. Through molecular design, manufacturers can precisely regulate polymer degradation rates to realize rapid drug release or sustained release lasting for weeks. For instance, adjusting the ratio of lactic acid to glycolic acid in PLGA controls its degradation period from several days to months. This facilitates the development of long-acting contraceptive patches and patches for chronic disease management such as diabetes.

II. The Impossible Triangle in Material Selection and Manufacturers' Balancing Expertise

For microneedle manufacturers, material selection always seeks the optimal balance within the "impossible triangle" consisting of mechanical strength, biocompatibility/degradability, and processability/cost.

• Mechanical strength: Needles must be rigid enough to pierce the stratum corneum (hardness: approximately 10–20 MPa) without being overly brittle and fractured. Degradable polymers are commonly reinforced via crosslinking, composite modification with nanomaterials such as hydroxyapatite, or optimization of microstructures.
• Biocompatibility and functionalization: Materials must be non-toxic and non-sensitizing, complying with biological evaluation requirements of the ISO 10993 series. Furthermore, materials can serve functional purposes. For example, dissolved hyaluronic acid acts as a natural skin moisturizer. Certain polymers are designed to respond to pH value, enzymes or temperature for intelligent on-demand drug release.
• Processing technology and cost: Materials must adapt to mass production. Micro-molding is the mainstream process for dissolvable microneedles: high-precision negative molds are fabricated from silicon or metal, followed by injection of polymer solution or melt. Products are demolded after drying or curing. This imposes strict requirements on material rheology, shrinkage rate and mold releasability. Manufacturers need to build a complete technical system covering mold design, material formulation and molding processes.

III. Application-oriented Customized Material Strategies

Leading manufacturers avoid pursuing universal materials, and instead provide customized material solutions for diverse application scenarios.

• Transdermal drug delivery and vaccination: Fast-dissolving materials such as PVP, sucrose and maltose are prioritized to achieve rapid release of vaccines, insulin and other drugs, with emphasis on drug loading efficiency and stability.
• Medical aesthetics and skincare: Hyaluronic acid and polylactic acid are widely adopted. Hyaluronic acid integrates puncture, moisturizing and skin repair functions; polylactic acid is popular in anti-aging applications due to its micro-damage repair mechanism that stimulates collagen regeneration.
• Diagnosis and monitoring: Microneedles for continuous interstitial fluid testing require excellent biocompatibility and electrochemical stability. Polymer or silicon-based materials coated with precious metals are commonly used.
• Hollow microneedles: Designed for delivery of high-volume liquid drugs. Materials need sufficient structural strength and excellent hollow channel formability. Coated silicon and engineering polymers such as PEEK are typical options.

IV. Cutting-edge Material R&D of Manufacturers

Top manufacturers are dedicated to developing next-generation materials:

• Composite materials: Polymers blended with functional nanoparticles (e.g., metal-organic frameworks, mesoporous silica) to increase drug loading capacity, achieve multi-stimuli responsive release or enable imaging functions.
• 4D printing materials: Intelligent hydrogels and similar materials are applied to produce microneedles that deform in response to external stimuli such as humidity and pH inside the body for more accurate drug delivery.
• Bionic materials: Structures inspired by mosquito mouthparts or cactus spines are adopted to design microneedles with lower penetration resistance and higher efficiency, usually combined with innovative new materials.

Conclusion

The material evolution history of microneedles witnesses a transformation from foreign body intervention to complete integration and absorption, and from passive tools to active intelligent devices. For manufacturers, materials are no longer mere product components, but strategic elements that define product performance, application scenarios and core competitiveness.

Driven by the boom of degradable polymers, manufacturers compete by virtue of in-depth understanding of material physical and chemical properties, precise and controllable processing technologies, and the capability to convert material characteristics into unique clinical value. In the future, enterprises that achieve a better balance among strength, biocompatibility and processability, and take the lead in commercializing stimuli-responsive smart materials will seize the commanding heights in the promising microneedle market.